Acute citalopram has different effects on regional 5-HT synthesis in FSL, FRL, and SDP rats: An autoradiographic evaluation

Brain Research Bulletin

Volumn 77, Issue 4, 2008, Pages 214-220

  Kanemaru, Kazuya ^a   Hasegawa, Shu ^a   Nishi, Kyoko ^a   Diksic, Mirko ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

14C methyl l tryptophan; Antidepressant; Autoradiography; Depression model; Tracer

Indexed keywords

ALPHA METHYL 1 TRYPTOPHAN C 14; CITALOPRAM; SEROTONIN; SODIUM CHLORIDE; TRYPTOPHAN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BASAL GANGLION; CONTROLLED STUDY; DEPRESSION; DORSAL RAPHE NUCLEUS; DRUG EFFECT; MALE; MEDIAN RAPHE NUCLEUS; NEOCORTEX; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; AUTORADIOGRAPHY; BRAIN; CITALOPRAM; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; MALE; RANDOM ALLOCATION; RATS; RATS, MUTANT STRAINS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SPECIES SPECIFICITY; TRYPTOPHAN;

EID: 54549103457     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2008.07.003     Document Type: Article

References (58)

1. Arborelius L., Nomikos G.G., Grillner P., Hertel P., Hook B.B., Hacksell U., and Svensson T.H. 5-HT1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram. Naunyn Schmiedebergs Arch. Pharmacol. 352 (1995) 157-165
2. Benkelfat C., Ellenbogen M.A., Dean P., Palmour R.M., and Young S.N. Enhanced susceptibility to the mood-lowering effect of tryptophan depletion in young male adults at genetic risk for major affective disorders. Arch. Gen. Psychiatry 51 (1994) 687-697
3. 11C]methyl-l-tryptophan PET study. Neurochem. Int. 52 (2008) 701-708
4. Bloxam D.L., and Curzon G. A study of proposed determinants of brain tryptophan concentration in rats after portocaval anastomosis or sham operation. J. Neurochem. 31 (1978) 1255-1263
5. David D.J., Bourin M., Jego G., Przybylski C., Jolliet P., and Gardier A.M. Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice. Br. J. Pharmacol. 140 (2003) 1128-1136
6. 1A agonists: animal models of anxiety and depression. In: Stall S.M. (Ed). Serotonin 1A Receptors in Depression and Anxiety (1992), Raven Press, New York 55-81
7. Diksic M., and Young S.N. Study of the brain serotonergic system with labeled alpha-methyl-l-tryptophan. J. Neurochem. 78 (2001) 1185-1200
8. Dremencov E., Newman M.E., Kinor N., Blatman-Jan G., Schindler C.J., Overstreet D.H., and Yadid G. Hyperfunctionality of serotonin-2C receptor-mediated inhibition of accumbal dopamine release in an animal model of depression is reversed by antidepressant treatment. Neuropharmacology 48 (2005) 34-42
9. Geyer M.A., Dawsey W.J., and Mandell A.J. Fading: a new cytofluorimetric measure quantifying serotonin in the presence of catecholamines at the cellular level in brain. J. Pharmacol. Exp. Ther. 207 (1978) 650-667
10. Gudelsky G.A., Koenig J.I., and Meltzer H.Y. Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-HT1A receptors. Neuropharmacology 25 (1986) 1307-1313
11. Harkin A., Kelly J.P., McNamara M., Connor T.J., Dredge K., Redmond R., and Leonard B.E. Activity and onset of action of reboxetine and effect of combination with setraline in an animal model of depression. Eur. J. Pharmacol. 364 (1999) 123-132
12. Hasegawa S., Nishi K., Watanabe A., Overstreet D.H., and Diksic M. Brain 5-HT synthesis in the Flinders Sensitive Line rat model of depression: an autoradiographic study. Neurochem. Int. 48 5 (2006) 358-366
13. Hasegawa S., Watanabe A., Nishi K., Nguyen K.Q., and Diksic M. Selective 5-HT(1B) receptor agonist reduces serotonin synthesis following acute, and not chronic, drug administration: results of an autoradiographic study. Neurochem. Int. 46 (2005) 261-272
14. Hjorth S. Serotonin 5-HT1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study. J. Neurochem. 60 (1993) 776-779
15. Hjorth S., and Auerbach S.B. Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors. Eur. J. Pharmacol. 260 (1994) 251-255
16. Hjorth S., Suchowski C.S., and Galloway M.P. Evidence for 5-HT autoreceptor-mediated, nerve impulse-independent, control of 5-HT synthesis in the rat brain. Synapse 19 (1995) 170-176
17. Invernizzi R., Belli S., and Samanin R. Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex. Brain Res. 584 (1992) 322-324
18. Jiménez-Vasquez P.A., Diaz-Cabiale Z., Caberlotto L., Bellido I., Overstreet D., Fuxe K., and Mathé A.A. Electroconvulsive stimuli selectively affect behavior and neuropeptide Y (NPY) and NPY Y(1) receptor gene expressions in hippocampus and hypothalamus of Flinders Sensitive Line rat model of depression. Eur. Neuropsychopharmacol. 17 (2007) 298-308
19. Kim S.W., Park S.Y., and Hwang O. Up-regulation of tryptophan hydroxylase expression and serotonin synthesis by sertraline. Mol. Pharmacol. 61 (2002) 778-785
20. Kiss J.P. Theory of active antidepressants: a nonsynaptic approach to the treatment of depression. Neurochem. Int. 52 (2008) 34-39
21. Maudhuit C., Jolas T., Chastanet M., Hamon M., and Adrien J. Reduced inhibitory potency of serotonin reuptake blockers on central serotoninergic neurons in rats selectively deprived of rapid eye movement sleep. Biol. Psychiatry 40 (1996) 1000-1007
22. Mayberg H.S., Liotti M., Brannan S.K., Mahurin R.K., McGinnis S., and Jerabek P.A. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am. J. Psychiatry 156 (1999) 675-682
23. Moret C., and Briley M. Effects of acute and repeated administration of citalopram on extracellular levels of serotonin in rat brain. Eur. J. Pharmacol. 295 (1996) 189-197
24. Mück-Seler D., and Diksic M. The acute effects of reserpine and NSD-1015 on the brain serotonin synthesis rate measured by an autoradiographic method. Neuropsychopharmacology 12 (1995) 251-262
25. Mück-Seler D., Jevric-Causevic A., and Diksic M. Influence of fluoxetine on regional serotonin synthesis in the rat brain. J. Neurochem. 67 (1996) 2434-2442
26. Nagahiro S., Takada A., Diksic M., Sourkes T.L., Missala K., and Yamamoto Y.L. A new method to measure brain serotonin synthesis in vivo. II. A practical autoradiographic method tested in normal and lithium-treated rats. J. Cereb. Blood Flow Metab. 10 (1990) 13-21
27. Nelson N. Presynaptic events involved in neurotransmission. J. Physiology (Paris) 87 (1993) 171-178
28. Neumeister A., Nugent A.C., Waldeck T., Gerici M., Schwartz M., Bonne O., Bain E.E., Luckenbaugh D.A., Hescovitch P., Charney D.S., and Drevets W.C. Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Arch. Gen. Psychiatry 61 (2004) 765-773
29. K.Q. Nguyen, Central serotonin synthesis in normal and OBX-rats: effects of citalopram alone and in combination with pindolol, M.Sc. Thesis, McGill University, Montreal, Quebec, Canada, 2002.
30. Nishizawa S., Benkelfat C., Young S.N., Leyton M., Mzengeza S., de Montigny C., Blier P., and Diksic M. Differences between males and females in rates of serotonin synthesis in human brain. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 5308-5313
31. Nishisawa S., Mzengeza S., and Diksic M. Acute effects of 3,4-methylenedioxymethamphetamine on brain serotonin synthesis in the dog studied by positron emission tomography. Neurochem. Int. 34 (1999) 33-40
32. Okazawa H., Yamane F., Blier P., and Diksic M. Effects of acute and chronic administration of the serotonin1A agonist buspirone on serotonin synthesis in the rat brain. J. Neurochem. 72 (1999) 2022-2031
33. Overstreet D.H. The Flinders Sensitive Line rats: a genetic animal model of depression. Neurosci. Biobehav. Rev. 17 (1993) 51-68
34. Overstreet D.H., Daws L.C., Schiller G.D., Orbach J., and Janowsky D.S. Cholinergic/serotonergic interactions in hypothermia: implications for rat models of depression. Pharmacol. Biochem. Behav. 59 (1998) 777-785
35. Overstreet D.H., Friedman E., Mathé A.A., and Yadid G. The Flinders Sensitive Line rat: a selectively bred putative animal model of depression. Neurosci. Biobehav. Rev. 29 (2005) 739-759 (Review)
36. Overstreet D.H., Keeney A., and Hogg S. Antidepressant effects of citalopram and CRF receptor antagonist CP-154,526 in a rat model of depression. Eur. J. Pharmacol. 492 (2004) 195-201
37. Overstreet D.H., Rezvani A.H., and Janowsky D.S. Genetic animal models of depression and ethanol preference provide support for cholinergic and serotonergic involvement in depression and alcoholism. Biol. Psychiatry 31 (1992) 919-936
38. Overstreet D.H., Russell R.W., Helps S.C., and Messenger M. Selective breeding for sensitivity to the anticholinesterase DFP. Psychopharmacology (Berlin) 65 (1979) 15-20
39. Overstreet D.H., Stemmelin J., and Griebel G. Confirmation of antidepressant potential of the selective beta3 adrenoceptor agonist amibegron in an animal model of depression. Pharmacol. Biochem. Behav. 89 (2008) 623-626
40. Rabiner E.A., Gunn R.N., Wilkins M.R., Sargent P.A., Mocaer E., Sedman E., Cowen P.J., and Grasby P.M. Drug action at the 5-HT(1A) receptor in vivo: autoreceptor and postsynaptic receptor occupancy examined with PET and [carbonyl-11C]WAY-100635. Nucl. Med. Biol. 27 (2000) 509-513
41. Russell R.W., Overstreet D.H., Messenger M., and Helps S.C. Selective breeding for sensitivity to DFP: generalization of effects beyond criterion variables. Pharmacol. Biochem. Behav. 17 (1982) 885-891
42. Salter M., Knowles R.G., and Aogson C.L. How dose displacement of albumin-bound tryptophan cause sustained increases in the free tryptophan concentration in plasma and 5-hydorxytryptamine synthesis in the brain?. Biochem. J. 262 (1989) 365-368
43. Schiller G.D. Altered behavioral sensitivity to serotonergic agonists in an animal model of depressive disorders: receptor binding correlates and cholineragic-serotonergic systems interaction. J. Neurochem. 57 (1991) S138
44. Shayit M., Yadid G., Overstreet D.H., and Weller A. 5-HT(1A) receptor subsensitivity in infancy and supersensitivity in adulthood in an animal model of depression. Brain Res. 980 (2003) 100-108
45. Stenfors C., Yu H., and Ross S.B. Pharmacological characterisation of the decrease in 5-HT synthesis in the mouse brain evoked by the selective serotonin re-uptake inhibitor citalopram. Naunyn Schmiedebergs Arch. Pharmacol. 363 (2001) 222-232
46. Takada A., Grdisa M., Diksic M., Gjedde A., and Yamamoto Y.L. Rapid steady-state analysis of blood-brain transfer of l-Trp in rat, with special reference to the plasma protein binding. Neurochem. Int. 23 (1993) 351-359
47. Tohyama Y., Mück-Seler D., and Diksic M. Acute flesinoxan treatment produces a different effect on rat brain serotonin synthesis than chronic treatment: an alpha-methyl-l-tryptophan autoradiographic study. Neurochem. Int. 51 (2007) 486-495
48. Tsuiki K., Yamamoto Y.L., and Diksic M. Effect of acute fluoxetine treatment on the brain serotonin synthesis as measured by the alpha-methyl-l-tryptophan autoradiographic method. J. Neurochem. 65 (1995) 250-256
49. Vanier M., Tsuiki K., Grdisa M., Worsley K., and Diksic M. Determination of the lumped constant for the alpha-methyltryptophan method of estimating the rate of serotonin synthesis. J. Neurochem. 64 (1995) 624-635
50. Vizi E.S. Modulation of cortical release of acetylcholine by noradrenaline released from nerves arising from the rat locus coeruleus. Neuroscience 5 (1980) 2139-2144
51. Vizi E.S., Zsilla G., Caron M.G., and Kiss J.P. Uptake and release of norepinephrine by serotonergic terminals in norepinephrine transporter knock-out mice: implications for the action of selective serotonin reuptake inhibitors. J. Neurosci. 24 (2004) 7888-7894
52. Wallis E., Overstreet D.H., and Crocker A.D. Selective breeding for increased cholinergic function: increased serotonergic sensitivity. Pharmacol. Biochem. Behav. 31 (1988) 345-350
53. Watanabe A., Tohyama Y., Nguyen K.Q., Hasegawa S., Debonnel G., and Diksic M. Regional brain serotonin synthesis is increased in the olfactory bulbectomy rat model of depression: an autoradiographic study. J. Neurochem. 85 (2003) 469-475
54. Wörtwein G., Husum H., Andersson W., Bolwig T.G., and Mathé A.A. Effects of maternal separation on neuropeptide Y and calcitonin gene-related peptide in "depressed" Flinders Sensitive Line rats: a study of gene-environment interactions. Prog. Neuropsychopharmacol. Biol. Psychiatry 30 (2006) 684-693
55. Yadid G., Nakash R., Deri I., Tamar G., Kinor N., Gispan I., and Zangen A. Elucidation of the neurobiology of depression: insights from a novel genetic animal model. Prog. Neurobiol. 62 (2000) 353-378
56. Yamane F., Tohyama Y., and Diksic M. Acute and chronic d-fenfluramine treatments have different effects on serotonin synthesis rates in the rat brain: an autoradiographic study. Neurochem. Res. 24 (1999) 1611-1620
57. Zambello E., Jiménez-Vasquez P.A., El Khoury A., Mathé A.A., and Caberlotto L. Acute stress differentially affects corticotropin-releasing hormone mRNA expression in the central amygdala of the "depressed" flinders sensitive line and the control flinders resistant line rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 32 (2008) 651-661
58. Zangen A., Overstreet D.H., and Yadid G. High serotonin and 5-hydroxyindoleacetic acid levels in limbic brain regions in a rat model of depression: normalization by chronic antidepressant treatment. J. Neurochem. 69 (1997) 2477-2483